Hotchkin DL - Search Results

1

Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.

Case AH, Beegle S, Hotchkin DL, Kaelin T, Kim HJ, Podolanczuk AJ, Ramaswamy M, Remolina C, Salvatore MM, Tu C, de Andrade JA. Case AH, et al. Among authors: hotchkin dl. BMJ Open Respir Res. 2023 Nov 24;10(1):e001594. doi: 10.1136/bmjresp-2022-001594. BMJ Open Respir Res. 2023. PMID: 38007235 Free PMC article.

2

Surge effects and survival to hospital discharge in critical care patients with COVID-19 during the early pandemic: a cohort study.

Dale CR, Starcher RW, Chang SC, Robicsek A, Parsons G, Goldman JD, Vovan A, Hotchkin D, Gluckman TJ. Dale CR, et al. Crit Care. 2021 Feb 17;25(1):70. doi: 10.1186/s13054-021-03504-w. Crit Care. 2021. PMID: 33596975 Free PMC article.

3

Predictors of time to death after terminal withdrawal of mechanical ventilation in the ICU.

Cooke CR, Hotchkin DL, Engelberg RA, Rubinson L, Curtis JR. Cooke CR, et al. Among authors: hotchkin dl. Chest. 2010 Aug;138(2):289-97. doi: 10.1378/chest.10-0289. Epub 2010 Apr 2. Chest. 2010. PMID: 20363840 Free PMC article. Clinical Trial.

4

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.

Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, Skowasch D, Park JS, Poonyagariyagorn HK, Wuyts W, Wells AU. Cottin V, et al. Among authors: hotchkin dl. Eur Respir Rev. 2018 Dec 21;27(150):180076. doi: 10.1183/16000617.0076-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578335 Free PMC article. Review.

5

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.

Snyder L, Neely ML, Hellkamp AS, O'Brien E, de Andrade J, Conoscenti CS, Leonard T, Bender S, Gulati M, Culver DA, Kaner RJ, Palmer S, Kim HJ; IPF-PRO™ Registry investigators. Snyder L, et al. Respir Res. 2019 May 30;20(1):105. doi: 10.1186/s12931-019-1043-9. Respir Res. 2019. PMID: 31142314 Free PMC article.

6

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.

Todd JL, Neely ML, Overton R, Durham K, Gulati M, Huang H, Roman J, Newby LK, Flaherty KR, Vinisko R, Liu Y, Roy J, Schmid R, Strobel B, Hesslinger C, Leonard TB, Noth I, Belperio JA, Palmer SM; IPF-PRO Registry investigators. Todd JL, et al. Respir Res. 2019 Oct 22;20(1):227. doi: 10.1186/s12931-019-1190-z. Respir Res. 2019. PMID: 31640794 Free PMC article. Clinical Trial.

7

Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.

O'Brien EC, Hellkamp AS, Neely ML, Swaminathan A, Bender S, Snyder LD, Culver DA, Conoscenti CS, Todd JL, Palmer SM, Leonard TB; IPF-PRO Registry investigators. O'Brien EC, et al. Chest. 2020 May;157(5):1188-1198. doi: 10.1016/j.chest.2019.11.042. Epub 2020 Jan 15. Chest. 2020. PMID: 31954102 Free article.

8

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.

Case AH, Hellkamp AS, Neely ML, Bender S, Dilling DF, Gulati M, Hotchkin DL, Huie TJ, Lancaster L, Snyder LD, Conoscenti CS, Palmer SM. Case AH, et al. Among authors: hotchkin dl. Ann Am Thorac Soc. 2020 Jun;17(6):699-705. doi: 10.1513/AnnalsATS.201906-437OC. Ann Am Thorac Soc. 2020. PMID: 32040340 Free PMC article.

9

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.

Todd JL, Vinisko R, Liu Y, Neely ML, Overton R, Flaherty KR, Noth I, Newby LK, Lasky JA, Olman MA, Hesslinger C, Leonard TB, Palmer SM, Belperio JA; IPF-PRO Registry investigators. Todd JL, et al. BMC Pulm Med. 2020 Mar 14;20(1):64. doi: 10.1186/s12890-020-1103-4. BMC Pulm Med. 2020. PMID: 32171287 Free PMC article.

10

Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.

Salisbury ML, Conoscenti CS, Culver DA, Yow E, Neely ML, Bender S, Hartmann N, Palmer SM, Leonard TB; IPF-PRO Registry principal investigators as follows. Salisbury ML, et al. Ann Am Thorac Soc. 2020 Nov;17(11):1413-1423. doi: 10.1513/AnnalsATS.201912-880OC. Ann Am Thorac Soc. 2020. PMID: 32574517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters